• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
LYU Hongyan.Reasrch progress on concomitant administration of oxcarbazepine with other drugs in the treatment of epilepsy and trigeminal neuralgia[J].Journal Of Pharmaceutical Research,2022,41(11):751-753,770[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2204times   Download 2207次 QR Code for this article
Scan with your phone!
奥卡西平联合用药治疗癫痫和三叉神经痛的研究进展
吕红艳
Font:Larger+|Default|Smaller-
(济宁市第一人民医院儿科,山东 济宁 272000)
摘要:
奥卡西平是常见的癫痫类用药,常用于治疗癫痫和三叉神经痛,具有较好的耐受性,在联合用药方面前景广阔。本文就近年来关于奥卡西平联合用药治疗癫痫及三叉神经痛的情况进行综述,为临床用药提供参考。
关键词:  奥卡西平  癫痫  三叉神经痛  联合用药
DOI:10.13506/j.cnki.jpr.2022.11.012
基金项目:
Publication Date:November 25, 2022
Reasrch progress on concomitant administration of oxcarbazepine with other drugs in the treatment of epilepsy and trigeminal neuralgia
LYU Hongyan
(Department of Pediatrics, Jining No.1 People's Hospital,Jining 272000, China)
Abstract:
Oxcarbazepine is a typical antiepileptic drug used to treat epilepsy and trigeminal neuralgia. Oxcarbazepine is well tolerated and has broad prospects in combination therapy. The paper reviewed the progress and discussed the advantages of oxcarbazepine concomitant administration in the treatment of epilepsy and trigeminal neuralgia, so as to provide research data and relevant support basis for clinical medication.
Key words:  Oxcarbazepine  Epilepsy  Trigeminal neuralgia  Concomitant administration
Today's Visits:527    Total Visits:2383269
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.